Internet Pioneer In...
Health Care: Drugs
Celsion Corporation (CLSN: NASDAQ)
$2.04 0.12 | 6.25%
06/04/12 - 04:00 PM ET
1.13M / 368.00K
Vol / Avg. Vol:1.98 / 1.92
Open / Prev. Close:1.96 - 2.13
Today's Range:1.63 - 4.37
52 Wk Range:12.94%
Performance YTD:TheStreet Rating:
Portfolios with CLSN
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorTop 5 Small-Cap Stocks to C...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- Contributor11 Biotech Stocks Loved or ...
- UserMy Portfolio
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Trades for Seco...
- Contributor10 Cheap Biotech Stocks Tha...
Latest CLSN Headlines from TheStreet
- Top 5 Small-Cap Stocks to Consider Buying 05.07.12 | 11:05 am
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- For Celsion, Patience May Be a Four-Letter Word 11.28.11 | 11:11 am
- Biotech Stock Mailbag: Vivus 09.16.11 | 05:09 am
- Biotech Stock Live Chat 09.15.11 | 11:09 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- Biotech Stock Live Chat 08.19.11 | 11:08 am
- Dendreon's Blowup Spreads Across Biotech 08.04.11 | 10:08 am
- 5 Stocks With Big Insider Buying 07.28.11 | 01:07 pm
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
Press Releases for CLSN
- Celsion Corporation Announces Completion Of $5.1 Million Registered Direct Offering - PR Newswire 01.21.11 | 03:01 pm
Partner Headlines for CLSN
- Celsion Completes Consultative Review Process With EMA for Phase III HEAT Study of ThermoDox in Primary Liver Cancer - Benzinga 12.19.11 | 09:12 am
- Will Celsion's Upcoming Catalysts Help The Price Break-Out Stick? - Seeking Alpha 10.31.11 | 09:10 am
- Upcoming Biotech Trials and Potential Tribulations - Seeking Alpha 04.13.11 | 09:04 am
